|
Originally published In Press as doi:10.1074/jbc.M603175200 on June 27, 2006
J. Biol. Chem., Vol. 281, Issue 34, 24721-24727, August 25, 2006
Regulation of Survivin Stability by the Aryl Hydrocarbon Receptor-interacting Protein*
Byoung Heon Kang1 and
Dario C. Altieri2
From the
Department of Cancer Biology and the Cancer Center, University of Massachusetts Medical School, Worcester, Massachusetts 01605
Survivin is a multifunctional member of the IAP (inhibitor of apoptosis) family, but its molecular interactions in protection from cell death and regulation of cell division have not been completely elucidated. In a proteomics screening to identify novel survivin-binding partners, we found that the aryl hydrocarbon receptor-interacting protein (AIP) directly associates with survivin in vitro and in co-immunoprecipitation experiments in vivo. This interaction is mediated by the carboxyl-terminal end of AIP, which contains three tetratricopeptide motifs, and involves the carboxyl terminus coiled coil in survivin with critical roles of Asp142 in AIP recognition. A survivin mutant lacking only Asp142 fails to bind AIP and exhibits accelerated degradation in vivo in a reaction reversed by a proteasome inhibitor. Acute knock-down of AIP by short interference RNA or competition of the survivin-AIP complex by peptidyl mimicry destabilizes survivin levels in cells, with enhanced apoptosis but no changes in cell cycle progression. Therefore, AIP regulates survivin stability, thus elevating a cellular anti-apoptotic threshold. The survivin-AIP complex may influence the cellular xenobiotic response to environmental toxin(s) and contribute to subcellular chaperone trafficking during cell death regulation.
Received for publication, April 4, 2006
, and in revised form, May 31, 2006.
* This work was supported by National Institutes of Health Grants CA90917, CA78810, and HL54131. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Supported by a post-doctoral fellowship program of Korea Science & Engineering Foundation.
2 To whom correspondence should be addressed: Dept. of Cancer Biology, LRB428, 364 Plantation St., Worcester, MA 01605. Tel.: 508-856-5775; Fax: 508-856-5792; E-mail: dario.altieri{at}umassmed.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Vargiolu, D. Fusco, I. Kurelac, D. Dirnberger, R. Baumeister, I. Morra, A. Melcarne, R. Rimondini, G. Romeo, and E. Bonora
The Tyrosine Kinase Receptor RET Interacts in Vivo with Aryl Hydrocarbon Receptor-Interacting Protein to Alter Survivin Availability
J. Clin. Endocrinol. Metab.,
July 1, 2009;
94(7):
2571 - 2578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Xia, P. M. Canovas, T. M. Guadagno, and D. C. Altieri
A Survivin-Ran Complex Regulates Spindle Formation in Tumor Cells
Mol. Cell. Biol.,
September 1, 2008;
28(17):
5299 - 5311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Leontiou, M. Gueorguiev, J. van der Spuy, R. Quinton, F. Lolli, S. Hassan, H. S. Chahal, S. C. Igreja, S. Jordan, J. Rowe, et al.
The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas
J. Clin. Endocrinol. Metab.,
June 1, 2008;
93(6):
2390 - 2401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Ghosh, T. Dohi, B. H. Kang, and D. C. Altieri
Hsp60 Regulation of Tumor Cell Apoptosis
J. Biol. Chem.,
February 22, 2008;
283(8):
5188 - 5194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Raj, T. Liu, G. Samadashwily, F. Li, and D. Grossman
Survivin repression by p53, Rb and E2F2 in normal human melanocytes
Carcinogenesis,
January 1, 2008;
29(1):
194 - 201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. Lin, R. Sullivan, Y. Lee, S. Moran, E. Glover, and C. A. Bradfield
Deletion of the Aryl Hydrocarbon Receptor-associated Protein 9 Leads to Cardiac Malformation and Embryonic Lethality
J. Biol. Chem.,
December 7, 2007;
282(49):
35924 - 35932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A Naves, A. F Daly, J.-F. Vanbellinghen, L. A Casulari, C. Spilioti, A. V Magalhaes, M. F Azevedo, L. A Giacomini, P. P Nascimento, R. O Nunes, et al.
Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene
Eur. J. Endocrinol.,
October 1, 2007;
157(4):
383 - 391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Karhu and L. A. Aaltonen
Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update
Hum. Mol. Genet.,
April 15, 2007;
16(R1):
R73 - R79.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Georgitsi, A. Raitila, A. Karhu, K. Tuppurainen, M. J. Makinen, O. Vierimaa, R. Paschke, W. Saeger, R. B. van der Luijt, T. Sane, et al.
Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations
PNAS,
March 6, 2007;
104(10):
4101 - 4105.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|